Skip to content

A positron emission tomography (PET) study to assess where the radiotracer [11C]AZ14132516 goes in the body following administration to healthy participants

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-502843-36-00
Acronym
D9690C00003
Enrollment
9
Registered
2023-04-03
Start date
2023-04-27
Completion date
2023-07-11
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease

Interventions

None listed

Sponsors

AstraZeneca AB, AstraZeneca AB
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026